✦ LIBER ✦
Efficacy of lanreotide Autogel® administered every 4–8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: a phase III trial
✍ Scribed by T. Lucas; R. Astorga; ; the Spanish–Portuguese Multicentre Autogel Study Group on Acromegaly
- Book ID
- 108703492
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 167 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0300-0664
No coin nor oath required. For personal study only.